Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (116)

2024

  1. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    DIABETES THERAPY

  2. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

2023

  1. CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

    Biology of Sex Differences, Vol. 14, Núm. 1

  2. Editorial: Central and peripheral mechanism interfering in metabolic syndrome

    Frontiers in Endocrinology

2022

  1. An updated view on human neonatal thermogenesis

    Nature Reviews Endocrinology

  2. Angiocrine polyamine production regulates adiposity

    Nature Metabolism, Vol. 4, Núm. 3, pp. 327-343

  3. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  4. Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 599-613

  5. Food Addiction in Eating Disorders: A Cluster Analysis Approach and Treatment Outcome

    Nutrients, Vol. 14, Núm. 5

  6. Food addiction and lifetime alcohol and illicit drugs use in specific eating disorders

    Journal of Behavioral Addictions, Vol. 11, Núm. 1, pp. 102-115

  7. Food addiction in anorexia nervosa: Implications for the understanding of crossover diagnosis

    European Eating Disorders Review, Vol. 30, Núm. 3, pp. 278-288

  8. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders

    Cell Metabolism, Vol. 34, Núm. 2, pp. 269-284.e9

  9. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

  10. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 15-28

  11. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  12. Liver Brain Interactions: Focus on FGF21 a Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  13. Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

    Reviews in Endocrine and Metabolic Disorders, Vol. 23, Núm. 5, pp. 919-930

  14. O-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease

    Frontiers in Endocrinology, Vol. 13

  15. Olfactomedin 2 deficiency protects against diet-induced obesity

    Metabolism: Clinical and Experimental, Vol. 129

  16. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917